Opportunity Information: Apply for CDC RFA DP21 2106
Advancing Arthritis Public Health Priorities through National Organizations (CDC RFA DP21-2106) is a CDC-led cooperative agreement funding opportunity created to improve the health, functioning, and overall quality of life of adults living with arthritis. The notice frames arthritis as a major but frequently underrecognized driver of chronic disease burden in the United States, contributing heavily to pain, disability, work limitations, and reduced day-to-day quality of life. It highlights the scale of the problem, citing more than 54 million U.S. adults living with arthritis, about half of whom are working age, and projections that roughly 78 million adults will have arthritis by 2040. The opportunity also emphasizes that arthritis often co-occurs with other serious chronic conditions such as heart disease, diabetes, and obesity, and that arthritis-related limitations can make those conditions harder to manage, particularly by reducing a persons ability or confidence to be physically active.
A central theme of the program is that arthritis symptoms and limitations can be improved through routine physical activity and participation in self-management education programs, yet proven interventions remain underused. The NOFO focuses on increasing the reach and uptake of low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) that have demonstrated benefits such as reduced pain, improved function, decreased disability, and better quality of life. While these programs exist in certain pockets of the country, the CDC points to persistent gaps in public awareness, limited availability in many communities, and insufficient clarity about how and where people can access these services. As a result, the funding is aimed at expanding both the supply of AAEBI offerings and the demand for them by improving visibility, accessibility, and participation nationwide.
To accomplish this, the NOFO is designed to leverage national organizations and partners that already have established systems, technologies, distribution channels, or networks capable of reaching large segments of the adult population. The intent is to create sustainable, scalable approaches that increase awareness of AAEBIs, expand their geographic dispersion, and drive higher enrollment and ongoing engagement. In addition to public-facing expansion work, the opportunity includes support for technical assistance to state health departments, along with providing arthritis-specific consumer health information to the public. Another priority is facilitating collaborative action around osteoarthritis (OA) specifically, while also addressing health equity and social determinants of health that can influence awareness of programs, access to services, and peoples ability to adopt and maintain effective self-management and physical activity behaviors.
The NOFO also calls for the development of a national strategy aimed at healthcare providers. This provider-focused strategy is intended to complement medication-based approaches by strengthening the emphasis on nonpharmacologic supports such as self-management education and physical activity as adjuncts to clinical care. In practical terms, the CDC is signaling that better arthritis outcomes will require stronger connections between clinical settings and community-based, evidence-based programs, as well as more consistent messaging and referral pathways so that patients hear about and can act on these options.
From an administrative standpoint, this is a discretionary, non-research funding opportunity under the CDC (HHS, CDC, NCCDPHP) using a cooperative agreement mechanism, meaning awardees should expect substantial engagement with CDC in implementing the work. The CFDA number is 93.945. The award ceiling is $1,000,000, with an expected total of 7 awards. Eligible applicants are broad and include various levels of government, public and private institutions of higher education, nonprofit organizations (including both 501(c)(3) and non-501(c)(3)), tribal governments and tribal organizations, public housing authorities, for-profit organizations (other than small businesses), and small businesses. The original closing date listed for applications was April 5, 2021, with electronic submissions due by 11:59 p.m. Eastern Time on the deadline.
Overall, the opportunity is structured around a public health strategy that moves beyond acknowledging arthritis as common and disabling and instead invests in practical, evidence-based tools that help people manage symptoms and stay active. The expected impact is improved arthritis management, better functional outcomes, and higher quality of life, achieved by expanding proven community interventions, strengthening statewide and national support capacity, addressing equity barriers, and aligning healthcare provider practices with self-management and physical activity approaches.Apply for CDC RFA DP21 2106
- The Department of Health and Human Services, Centers for Disease Control - NCCDPHP in the health sector is offering a public funding opportunity titled "Advancing Arthritis Public Health Priorities through National Organizations" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.945.
- This funding opportunity was created on Jan 14, 2021.
- Applicants must submit their applications by Apr 05, 2021 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- The number of recipients for this funding is limited to 7 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the "Advancing Arthritis Public Health Priorities through National Organizations" funding opportunity?
It is a CDC-led cooperative agreement funding opportunity (RFA DP21-2106) intended to improve the health, functioning, and overall quality of life of adults living with arthritis by expanding the reach and use of proven, arthritis-appropriate public health interventions.
Which federal agency is offering this opportunity?
The opportunity is offered by the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), within NCCDPHP.
What is the funding mechanism for this award?
This opportunity uses a cooperative agreement mechanism. That means recipients should expect substantial engagement with CDC during implementation, rather than operating with minimal federal involvement.
Is this considered a research grant?
No. The notice describes it as a discretionary, non-research funding opportunity focused on implementation and public health impact.
What public health problem is this program trying to address?
The notice frames arthritis as a major and often underrecognized driver of chronic disease burden in the United States, contributing to pain, disability, work limitations, and reduced day-to-day quality of life. It also emphasizes the large and growing number of adults affected.
How common is arthritis, according to the notice?
The notice cites more than 54 million U.S. adults living with arthritis, about half of whom are working age, and it projects that roughly 78 million adults will have arthritis by 2040.
How does arthritis relate to other chronic conditions?
The opportunity notes that arthritis often co-occurs with other serious chronic conditions such as heart disease, diabetes, and obesity. It also highlights that arthritis-related limitations can make those conditions harder to manage, particularly by reducing a person's ability or confidence to be physically active.
What kinds of interventions does the CDC want to expand through this program?
The focus is on expanding low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs), including routine physical activity approaches and self-management education programs that have demonstrated benefits like reduced pain, improved function, decreased disability, and better quality of life.
What does AAEBI stand for in this opportunity?
AAEBI refers to low-cost, arthritis-appropriate, evidence-based interventions.
Why is the program emphasizing physical activity and self-management education?
The notice states that arthritis symptoms and limitations can be improved through routine physical activity and participation in self-management education programs, but these proven interventions remain underused.
What gaps or barriers is this funding meant to address?
The notice points to persistent gaps in public awareness, limited availability of programs in many communities, and insufficient clarity about how and where people can access these services. The funding aims to expand both the supply of AAEBI offerings and the demand for them by improving visibility, accessibility, and participation nationwide.
Why does the NOFO emphasize national organizations?
The NOFO is designed to leverage national organizations and partners that already have established systems, technologies, distribution channels, or networks capable of reaching large segments of the adult population, with the intent of creating sustainable and scalable approaches.
What are the main goals or outcomes the CDC is seeking?
Based on the notice, the intended outcomes include increased awareness and reach of AAEBIs, broader geographic dispersion of program offerings, higher enrollment and ongoing engagement, improved arthritis management, better functional outcomes, and improved quality of life for adults with arthritis.
Does the opportunity include work beyond public-facing program expansion?
Yes. The opportunity includes support for providing technical assistance to state health departments and providing arthritis-specific consumer health information to the public.
Is osteoarthritis (OA) specifically mentioned as a priority?
Yes. The NOFO highlights facilitating collaborative action around osteoarthritis (OA) specifically, while also addressing arthritis more broadly.
How does health equity fit into the NOFO?
The notice includes an emphasis on health equity and social determinants of health that can affect awareness of programs, access to services, and people's ability to adopt and maintain effective self-management and physical activity behaviors.
Is there a healthcare provider component in this opportunity?
Yes. The NOFO calls for development of a national strategy aimed at healthcare providers to complement medication-based approaches by strengthening emphasis on nonpharmacologic supports such as self-management education and physical activity as adjuncts to clinical care.
What does the provider-focused strategy aim to change in practice?
The notice signals a need for stronger connections between clinical settings and community-based evidence-based programs, along with more consistent messaging and referral pathways so patients learn about and can act on self-management and physical activity options.
What is the CFDA number for this opportunity?
The CFDA number listed is 93.945.
What is the maximum award amount (ceiling) per award?
The award ceiling is $1,000,000.
How many awards does the notice expect to make?
The notice states an expected total of 7 awards.
Who is eligible to apply?
Eligible applicants are broad and include various levels of government, public and private institutions of higher education, nonprofit organizations (including both 501(c)(3) and non-501(c)(3)), tribal governments and tribal organizations, public housing authorities, for-profit organizations (other than small businesses), and small businesses.
Are for-profit organizations eligible?
Yes. The eligibility list includes for-profit organizations (other than small businesses) and also separately includes small businesses.
Are tribal governments and tribal organizations eligible?
Yes. The eligibility list includes tribal governments and tribal organizations.
Are colleges and universities eligible?
Yes. The eligibility list includes public and private institutions of higher education.
Is this opportunity open to government entities?
Yes. The eligibility list includes various levels of government.
What was the application deadline listed in the notice?
The original closing date listed was April 5, 2021.
What time were electronic submissions due on the deadline date?
Electronic submissions were due by 11:59 p.m. Eastern Time on the deadline.
What does the CDC mean by expanding both "supply" and "demand" for interventions?
As described in the notice, "supply" refers to increasing the availability and geographic dispersion of AAEBI offerings. "Demand" refers to increasing awareness, visibility, accessibility, participation, enrollment, and ongoing engagement in those programs.
What is the intended approach to scaling interventions nationally?
The NOFO emphasizes leveraging national systems, technologies, distribution channels, and networks to reach large segments of the adult population and to build sustainable, scalable approaches that increase awareness and participation nationwide.
What types of benefits does the notice associate with AAEBIs?
The notice states that evidence-based interventions have demonstrated benefits including reduced pain, improved function, decreased disability, and better quality of life.
Browse more opportunities from the same category: Health
Next opportunity: SmartTots (Strategies for Mitigating Anesthesia-Related neuroToxicity in Tots) Public-Private Partnership (PPP) under PASI (Pediatric Anesthesia Safety Initiative) (U01) Clinical Trials Not Allowed
Previous opportunity: Limited Competition: National Institute on Aging (NIA) Late Onset of Alzheimers Disease (LOAD) Family-Based Study (FBS) (U24 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DP21 2106
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DP21 2106) also looked into and applied for these:
| Funding Opportunity |
|---|
| Vision Screening in Young Children Program Apply for HRSA 21 033 Funding Number: HRSA 21 033 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| HIV/TB Agency, Information, and Services Activity (HIV/TB AIS) Apply for 72048221RFA00001 Funding Number: 72048221RFA00001 Agency: Agency for International Development, Burma USAID - Rangoon Category: Health Funding Amount: $39,000,000 |
| USAID Improved Family Planning Initiative Apply for 72065621RFA00001 IFPI Funding Number: 72065621RFA00001 IFPI Agency: Agency for International Development, Mozambique USAID-Maputo Category: Health Funding Amount: $39,900,011 |
| Autism Field-Initiated Innovative Research Studies Program (Autism-FIRST) Apply for HRSA 21 053 Funding Number: HRSA 21 053 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| SPOTLIGHT: A Social Medicine, HIV Provider Stigma and Bias Prevention Project Apply for 72052121RFA00001 Funding Number: 72052121RFA00001 Agency: Agency for International Development, Haiti USAID-Port Au Prince Category: Health Funding Amount: $900,000 |
| Promoting Cancer Surveillance Workforce, Education, and Data Use Apply for CDC RFA DP21 2104 Funding Number: CDC RFA DP21 2104 Agency: Department of Health and Human Services, Centers for Disease Control - NCCDPHP Category: Health Funding Amount: $500,000 |
| Advancing Comprehensive Community-Based HIV Services to Achieve Epidemic Control in Namibia under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH21 2153 Funding Number: CDC RFA GH21 2153 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Bridging the Word Gap Research Network (BWG) Apply for HRSA 21 040 Funding Number: HRSA 21 040 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Money Follows the Person Rebalancing Demonstration Program - Capacity Building Apply for CMS 1LI 21 001 Funding Number: CMS 1LI 21 001 Agency: Department of Health and Human Services, Centers for Medicare Medicaid Services Category: Health Funding Amount: $5,000,000 |
| NIOSH Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed) Apply for PAR 21 148 Funding Number: PAR 21 148 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $20,000 |
| Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24) Apply for RFA OH 21 007 Funding Number: RFA OH 21 007 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $1,100,000 |
| The Microbicide 2021 Introduction and Access Project Apply for 7200AA21RFA00008 Funding Number: 7200AA21RFA00008 Agency: Agency for International Development Category: Health Funding Amount: $85,000,000 |
| President's Malaria Initiative Eliminate Malaria (PMI-EM) Activity Apply for 72048221RFA00002 Funding Number: 72048221RFA00002 Agency: Agency for International Development, Burma USAID - Rangoon Category: Health Funding Amount: $30,000,000 |
| Military Health System Research (MHSR) Apply for 22 DHA MHSR Funding Number: 22 DHA MHSR Agency: Department of Defense, Defense Health Agency Category: Health Funding Amount: $10,000,000 |
| Comprehensive Addiction and Recovery Act (CARA) Local Drug Crises Grants Apply for CDC RFA CE21 2103 Funding Number: CDC RFA CE21 2103 Agency: Department of Health and Human Services, Centers for Disease Control - NCIPC Category: Health Funding Amount: $50,000 |
| Service Delivery for HIV Prevention Apply for 72061121RFA00001 Funding Number: 72061121RFA00001 Agency: Agency for International Development, Zambia USAID-Lusaka Category: Health Funding Amount: $75,000,000 |
| Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation’s Health Apply for CDC RFA OT18 18020301SUPP21 Funding Number: CDC RFA OT18 18020301SUPP21 Agency: Department of Health and Human Services, Centers for Disease Control - OSTLTS Category: Health Funding Amount: $250,000 |
| High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) Apply for PAR 21 126 Funding Number: PAR 21 126 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) Apply for PAR 21 127 Funding Number: PAR 21 127 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $600,000 |
| Human Immunology Project Consortium (HIPC) Coordinating Center (U01 Clinical Trial Not Allowed) Apply for RFA AI 20 080 Funding Number: RFA AI 20 080 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $1,200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DP21 2106", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.